Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: Association with pathology, severity, and structural brain changes

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Summary for Policymakers

(2014) · Climate Change 2013 – The Physical Science Basis · doi:10.1017/cbo9781107415324.004 · Cited by 23,880 · see citing works

[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].

Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,010 · see citing works

Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review

Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589 · see citing works

Older Adults' Reasons for Using Technology while Aging in Place

Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,803 · see citing works

Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly

Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,003 · see citing works

2016 Alzheimer's disease facts and figures

Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069 · see citing works

. Cerebral blood flow in dementia.

Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R., & Symon, L. (1975) · Archives of Neurology · doi:10.1001/archneur.1975.00490510088009 · Cited by 3,186 · see citing works

Overview of the MNA--Its history and challenges.

Vellas, B. J., Villars, H., van Kan, G. A., Soto, M. E., Rolland, Y., Guigoz, Y., Morley, J. E., Chumlea, W. M. C., Salvà, A., Rubenstein, L. Z., et al. (2006) · PubMed · Cited by 910 · see citing works

Metabolic network failures in Alzheimer's disease: A biochemical road map

Toledo, J. B., Arnold, M., Kastenmüller, G., Chang, R. R., Baillie, R., Han, X., Thambisetty, M., Tenenbaum, J. D., Suhre, K., Thompson, J. W., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.01.020 · Cited by 454 · see citing works

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics

Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M., & Petersen, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063644 · Cited by 438 · see citing works

Regulation of nitric oxide production in health and disease

Luiking, Y. C., ENGELEN, M. P. K. J., & Deutz, N. E. P. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328332f99d · Cited by 332 · see citing works

Free amino acid and dipeptide changes in the body fluids from Alzheimer’s disease subjects

Fonteh, A. N., Harrington, R. J., Tsai, A., Liao, P. S., & Harrington, M. G. (2006) · Amino Acids · doi:10.1007/s00726-006-0409-8 · Cited by 248 · see citing works

Endothelial nitric oxide: protector of a healthy mind

Katušić, Z. S., & Austin, S. A. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht544 · Cited by 222 · see citing works

Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease

Graham, S. F., Chevallier, O. P., Elliott, C. T., Hölscher, C., Johnston, J. A., McGuinness, B., Kehoe, P. G., Passmore, A. P., & Green, B. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119452 · Cited by 184 · see citing works

Toward a Predictive Model of Alzheimer’s Disease Progression Using Capillary Electrophoresis–Mass Spectrometry Metabolomics

Ibáñez, C., Simó, C., Martín‐Álvarez, P. J., Kivipelto, M., Winblad, B. G., Cedazo-Mı́nguez, Á., & Cifuentes, A. (2012) · Analytical Chemistry · doi:10.1021/ac301243k · Cited by 166 · see citing works

Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer’s disease

Selley, M. L. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00007-1 · Cited by 159 · see citing works

Clinical Criteria for Vascular Dementia: The NINDS-AIREN Criteria

Erkinjuntti, T. (1994) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106721 · Cited by 137 · see citing works

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke

Schulze, F., Carter, A. M., Schwedhelm, E., Ajjan, R., Maas, R., von Holten, R.-A., Atzler, D., Grant, P. J., & Böger, R. H. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.039 · Cited by 124 · see citing works

A Blood-Based, 7-Metabolite Signature for the Early Diagnosis of Alzheimer's Disease

Olazarán, J., Gil‐de‐Gómez, L., Rodríguez‐Martín, A., Valentí, M., Payo, B. F., Marín-Muñoz, J., Antúnez, C., Frank, A., Acedo, C., Gracia, L. M., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142925 · Cited by 116 · see citing works

Imaging biomarkers of dementia: recommended visual rating scales with teaching cases

From the Imaging Cognitive Impairment Network (ICINET), Wahlund, L., Westman, E., van Westen, D., Wallin, A., Shams, S., Cavallin, L., & Larsson, E. (2016) · Insights into Imaging · doi:10.1007/s13244-016-0521-6 · Cited by 114 · see citing works

Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders

El‐Hattab, A. W., Emrick, L., Craigen, W. J., & Scaglia, F. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.06.018 · Cited by 104 · see citing works

Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography–mass spectrometry as pentafluorobenzamide derivative: Evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease

Tsikas, D., Thum, T., Becker, T., Pham, V. V., Chobanyan-Jürgens, K., Mitschke, A., Beckmann, B., Gutzki, F., Bauersachs, J. K., & Stichtenoth, D. O. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.015 · Cited by 95 · see citing works

Endogenous formation of dimethylamine

Zeisel, S. H., daCosta, K.-A., & Fox, J. G. (1985) · Biochemical Journal · doi:10.1042/bj2320403 · Cited by 93 · see citing works

Using direct infusion mass spectrometry for serum metabolomics in Alzheimer’s disease

González‐Domínguez, R., García‐Barrera, T., & Gómez‐Ariza, J. L. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8102-3 · Cited by 91 · see citing works

Quantitative structural MRI for early detection of Alzheimer's disease

McEvoy, L. K., & Brewer, J. B. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.162 · Cited by 90 · see citing works

Association of Plasma ADMA Levels With MRI Markers of Vascular Brain Injury: Framingham Offspring Study

Pikula, A., Böger, R. H., Beiser, A. S., Maas, R., DeCarli, C., Schwedhelm, E., Himali, J. J., Schulze, F., Au, R., Kelly-Hayes, M., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.557116 · Cited by 85 · see citing works

Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance

Krzystek‐Korpacka, M., Diakowska, D., Kapturkiewicz, B., Bębenek, M., & Gamian, A. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.033 · Cited by 84 · see citing works

The toxicity of dimethylamine in F-344 rats and B6C3F1 mice following a 1-year inhalation exposure*1

BUCKLEY, L. (1985) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(85)90082-x · Cited by 83 · see citing works

Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia

Corso, G., Cristofano, A., Sapere, N., la Marca, G., Angiolillo, A., Vitale, M., Fratangelo, R., Lombardi, T., Porcile, C., Intrieri, M., et al. (2017) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000466688 · Cited by 79 · see citing works

Does Obesity Increase the Risk of Dementia: A Literature Review

Anjum, I., Fayyaz, M., Abdullah, W., Sohail, W., & Ali, A. (2018) · Cureus · doi:10.7759/cureus.2660 · Cited by 79 · see citing works

Cardiovascular Disease, the Nitric Oxide Pathway and Risk of Cognitive Impairment and Dementia

Stephan, B. C. M., Harrison, S. L., Keage, H. A. D., Babateen, A. M., Robinson, L. A., & Siervo, M. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0898-y · Cited by 77 · see citing works

Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study

Notsu, Y., Yano, S., Shibata, H., Nagai, A., & Nabika, T. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.030 · Cited by 66 · see citing works

8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease

Ganetzky, R. D., & Falk, M. J. (2018) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2018.01.010 · Cited by 65 · see citing works

Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function

Lüneburg, N., von Holten, R.-A., Töpper, R., Schwedhelm, E., Maas, R., & Böger, R. H. (2011) · Clinical Science · doi:10.1042/cs20110013 · Cited by 56 · see citing works

Potential serum biomarkers in the pathophysiological processes of stroke

Miao, Y., & Liao, J. K. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.875471 · Cited by 55 · see citing works

Asymmetrical Dimethylarginine Is Increased in Plasma and Decreased in Cerebrospinal Fluid of Patients with Alzheimer’s Disease

Arlt, S., Schulze, F., Eichenlaub, M., Maas, R., Lehmbeck, J. T., Schwedhelm, E., Jahn, H., & Böger, R. H. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000144026 · Cited by 53 · see citing works

Redox Control of Protein Arginine Methyltransferase 1 (PRMT1) Activity

Morales, Y., Nitzel, D. V., Price, O. M., Gui, S., Li, J., Qu, J., & Hevel, J. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.651380 · Cited by 53 · see citing works

Altered plasma arginine metabolome precedes behavioural and brain arginine metabolomic profile changes in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease

Bergin, D., Yu, J. H., Mockett, B., Zhang, H., Abraham, W. C., & Liu, P. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0149-z · Cited by 50 · see citing works

L-Arginine Levels in Blood as a Marker of Nitric Oxide–Mediated Brain Damage in Acute Stroke: A Clinical and Experimental Study

Armengou, A., Hurtado, O., Leira, R., Obón, M., Pascual, C., Moro, M. Á., Lizasoaín, I., Castillo, J., & Dávalos, A. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000080651.64357.c6 · Cited by 40 · see citing works

Quantitative Analysis of l-Arginine, Dimethylated Arginine Derivatives, l-Citrulline, and Dimethylamine in Human Serum Using Liquid Chromatography–Mass Spectrometric Method

Fleszar, M. G., Wiśniewski, J. Ł., Krzystek‐Korpacka, M., Misiak, B., Frydecka, D., Piechowicz, J., Lorenc-Kukuła, K., & Gamian, A. (2018) · Chromatographia · doi:10.1007/s10337-018-3520-6 · Cited by 40 · see citing works

Dimethylarginines, Homocysteine Metabolism, and Cerebrospinal Fluid Markers for Alzheimer's Disease

Arlt, S., Schwedhelm, E., Kölsch, H., Jahn, H., Linnebank, M., Smulders, Y. M., Jessen, F., Böger, R. H., & Popp, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112138 · Cited by 39 · see citing works

Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development

Murphy, R. B., Tommasi, S., Lewis, B. C., & Mangoni, A. A. (2016) · Molecules · doi:10.3390/molecules21050615 · Cited by 38 · see citing works

Association of dimethylarginines and mediators of inflammation after acute ischemic stroke

Chen, S., Martens‐Lobenhoffer, J., Weißenborn, K., Kielstein, J. T., Lichtinghagen, R., Deb‐Chatterji, M., Li, N., Tryc, A. B., Goldbecker, A., Dong, Q., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-251 · Cited by 37 · see citing works

Inducible Nitric Oxide Synthase Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries from Hypothyroid Rats

Virdis, A., Colucci, R., Fornai, M., Polini, A., Daghini, E., Duranti, E., Ghisu, N., Versari, D., Dardano, A., Blandizzi, C., et al. (2008) · Endocrinology · doi:10.1210/en.2008-1112 · Cited by 36 · see citing works

Next-generation biomarker discovery in Alzheimer’s disease using metabolomics–from animal to human studies

Hurtado, M. O., Kohler, I., & de Lange, E. C. M. (2018) · Bioanalysis · doi:10.4155/bio-2018-0135 · Cited by 34 · see citing works

Circulating midkine in malignant and non-malignant colorectal diseases

Krzystek‐Korpacka, M., Diakowska, D., Neubauer, K., & Gamian, A. (2013) · Cytokine · doi:10.1016/j.cyto.2013.07.008 · Cited by 32 · see citing works

Down-regulation of Asymmetric Arginine Methylation During Replicative and H2O2-induced Premature Senescence in WI-38 Human Diploid Fibroblasts

Lim, Y., Lee, E., Lee, J., Oh, S., & Kim, S. H. (2008) · The Journal of Biochemistry · doi:10.1093/jb/mvn097 · Cited by 30 · see citing works

Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid

Mulder, C., Wahlund, L., Blomberg, M. I., de Jong, S., van Kamp, G. J., Scheltens, P., & Teerlink, T. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-002-0760-1 · Cited by 29 · see citing works

Validation of an International Statistical Classification of Diseases and Related Health Problems 10th Revision Coding Algorithm for Hospital Encounters with Hypoglycemia

Hodge, M. C., Dixon, S. N., Garg, A. X., & Clemens, K. K. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2016.11.003 · Cited by 28 · see citing works

Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia.

Mochizuki, Y., Oishi, M., Hara, M., & Takasu, T. (1996) · PubMed · Cited by 25 · see citing works

Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality—Should Patients with Elevated Levels Be Supplemented with Citrulline?

McCarty, M. (2016) · Healthcare · doi:10.3390/healthcare4030040 · Cited by 25 · see citing works

Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS)

Krzystek‐Korpacka, M., Wiśniewski, J. Ł., Fleszar, M. G., Bednarz-Misa, I. S., Bronowicka-Szydełko, A., Gacka, M., Masłowski, L., Kędzior, K., Witkiewicz, W., & Gamian, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5965721 · Cited by 20 · see citing works

l-Arginine intervention at hyper-acute phase protects the prolonged MRI abnormality in MELAS

Kitamura, M., Yatsuga, S., Abe, T., Povalko, N., Saiki, R., Ushijima, K., Yamashita, Y., & Koga, Y. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8069-4 · Cited by 19 · see citing works

Population-level pharmacogenomics for precision drug development in dementia

Cacabelos, R. (2018) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2018.1468218 · Cited by 16 · see citing works

Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD

Neubauer, K., Matusiewicz, M., Bednarz-Misa, I. S., Górska, S., Gamian, A., & Krzystek‐Korpacka, M. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/7265812 · Cited by 13 · see citing works

Endogenous Hydrogen Sulfide is Involved in Asymmetric Dimethylarginine-induced Protection Against Neurotoxicity of 1-Methyl-4-phenyl-pyridinium Ion

Tang, X., Fang, H., Li, Y., Zhou, C., Ren, Y., Chen, R., Wang, C., & Hu, B. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0542-y · Cited by 12 · see citing works

Working Memory and Aphasia

Kasselimis, D. S. (2015) · International Journal of Neurology Research · doi:10.17554/j.issn.2313-5611.2015.01.27 · Cited by 7 · see citing works

Homocysteine and asymmetric dimethylarginine concentrations in the plasma of Alzheimer’s disease patients with varying degrees of dementia

Dorszewska, J., Florczak‐Wyspianska, J., Oczkowska, A., Dezor, M., Prendecki, M., & Kozubski, W. P. (2013) · Advances in Alzheimer s Disease · doi:10.4236/aad.2013.21001 · Cited by 6 · see citing works

Changes of nutritional habits in patients with Alzheimer's disease

Ciszewska-Czarnecka, K., & Kłoszewska, I. (2016) · Postępy Psychiatrii i Neurologii · doi:10.1016/j.pin.2016.02.001 · Cited by 3 · see citing works

New Insights into Possible Role of NOS-NO-ADMA Pathway Dysfunction in the Development of Cognitive Decline and Dementia: Exploring the Vascular Features of Alzheimer’s Disease

Začiragić, A. (2015) · International Journal of Neurology Research · doi:10.17554/j.issn.2313-5611.2015.01.15 · Cited by 3 · see citing works

Plasma Citrulline: A New Marker of Gut Epithelium Alteration in Obese Patients?

Benedini, S., Fermo, I., Caumo, A., Terruzzi, I. M., & Luzi, L. (2015) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2015.54028 · Cited by 2 · see citing works

Contents

(2016) · Alzheimer s & Dementia · doi:10.1016/s1552-5260(15)03007-1 · Cited by 2 · see citing works

Clinical Dementia Rating Scale (CDR) and dementia risk in the Mild Cognitive Impairment patients

Barczak, A. K., Gabryelewicz, T., Wasiak, B., Golan, M. P., Chodakowska-Żebrowska, M., Pfeffer, A., Styczyńska, M., Mandecka, M., & Barcikowska, M. (2013) · Postępy Nauk Medycznych · Cited by 1 · see citing works

L-Arginine Pathway Metabolites Predict 6 Months Outcome after Acute Ischemic Stroke

Csécsei, P., Nagy, L., Kéki, S., Szapáry, L. B., Illés, Z., Farkas, N., & Molnár, T. (2018) · International Journal of Neurorehabilitation · doi:10.4172/2376-0281.1000315 · Cited by 1 · see citing works

Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery

Buccellato, F. R., D’Anca, M., Fenoglio, C., Scarpini, E., & Galimberti, D. (2021) · Antioxidants · doi:10.3390/antiox10091353 · Cited by 179 · see citing works

Relationship between Central Obesity and the incidence of Cognitive Impairment and Dementia from Cohort Studies Involving 5,060,687 Participants

Tang, X., Zhao, W., Lu, M., Zhang, X., Zhang, P., Xin, Z., Sun, R., Tian, W., Cardoso, M. A., Yang, J., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.08.028 · Cited by 154 · see citing works

The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches

Zhu, H.-Y., Hong, F.-F., & Yang, S.-L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094540 · Cited by 84 · see citing works

Integrated multi-omics analysis of Alzheimer’s disease shows molecular signatures associated with disease progression and potential therapeutic targets

Kodam, P., Sai Swaroop, R., Pradhan, S. S., Sivaramakrishnan, V., & Vadrevu, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-30892-6 · Cited by 82 · see citing works

Update on the Neurobiology of Vascular Cognitive Impairment: From Lab to Clinic

Vinciguerra, L., Lanza, G., Puglisi, V., Fisicaro, F., Pennisi, M., Bella, R., & Cantone, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082977 · Cited by 69 · see citing works

Peripheral nitric oxide signaling directly blocks inflammatory pain

Gomes, F. I. F., Cunha, F. Q., & Cunha, T. M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113862 · Cited by 63 · see citing works

Alzheimer's disease as an innate autoimmune disease (AD 2 ): A new molecular paradigm

Weaver, D. F. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12789 · Cited by 60 · see citing works

Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings

Krzystek‐Korpacka, M., Fleszar, M. G., Bednarz-Misa, I. S., Lewandowski, Ł., Szczuka, I., Kempiński, R., & Neubauer, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051641 · Cited by 51 · see citing works

Arginine Derivatives in Cerebrovascular Diseases: Mechanisms and Clinical Implications

Große, G. M., Schwedhelm, E., Worthmann, H., & Choe, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051798 · Cited by 51 · see citing works

Insulin resistance in Alzheimer’s disease: The genetics and metabolomics links

Amin, A. M., Mostafa, H. M. A., & Khojah, H. M. J. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.016 · Cited by 43 · see citing works

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs

Krzystek‐Korpacka, M., Szczęśniak-Sięga, B. M., Szczuka, I., Fortuna, P., Zawadzki, M., Kubiak, A., Mierzchała-Pasierb, M., Fleszar, M. G., Lewandowski, Ł., Serek, P., et al. (2020) · Cancers · doi:10.3390/cancers12092594 · Cited by 37 · see citing works

The emerging role of nitric oxide in the synaptic dysfunction of vascular dementia

Zhang, X., Chen, Z., Xiong, Y., Zhou, Q., Zhu, L., & Liu, D. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01353 · Cited by 39 · see citing works

Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer’s disease (from the Nakayama Study)

Ozaki, T., Yoshino, Y., Tachibana, A., Shimizu, H., Mori, T., Nakayama, T., Mawatari, K., Numata, S., Iga, J., Takahashi, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-19670-y · Cited by 35 · see citing works

The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment

Weng, W., Huang, W., Tang, H.-Y., Cheng, M., & Chen, K. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01223 · Cited by 33 · see citing works

Saffron extract (Safr'Inside™) improves anxiety related behaviour in a mouse model of low-grade inflammation through the modulation of the microbiota and gut derived metabolites

Pontifex, M. G., Connell, E., Gall, G. L., Pourtau, L., Gaudout, D., Angeloni, C., Zallocco, L., Ronci, M., Giusti, L., Müller, M. M., et al. (2022) · Food & Function · doi:10.1039/d2fo02739a · Cited by 31 · see citing works

Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence

Amidfar, M., Askari, G., & Kim, Y. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110848 · Cited by 33 · see citing works

Small Vessel Disease: Ancient Description, Novel Biomarkers

Moretti, R., & Caruso, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073508 · Cited by 25 · see citing works

L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery

Bednarz-Misa, I. S., Fleszar, M. G., Zawadzki, M., Kapturkiewicz, B., Kubiak, A., Neubauer, K., Witkiewicz, W., & Krzystek‐Korpacka, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061782 · Cited by 24 · see citing works

Arginase 1 Insufficiency Precipitates Amyloid-β Deposition and Hastens Behavioral Impairment in a Mouse Model of Amyloidosis

Ma, C., Hunt, J. B., Selenica, M.-L. B., Sanneh, A., Sandusky-Beltran, L. A., Watler, M., Daas, R., Kovalenko, A., Liang, H., Placides, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582998 · Cited by 24 · see citing works

KL1 Domain of Longevity Factor Klotho Mimics the Metabolome of Cognitive Stimulation and Enhances Cognition in Young and Aging Mice

Gupta, S., Moreno, A. J., Wang, D., Leon, J., Chen, C., Hahn, O., Poon, Y., Greenberg, K., David, N. E., Wyss‐Coray, T., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2458-21.2022 · Cited by 25 · see citing works

Insulin Resistance, a Risk Factor for Alzheimer’s Disease: Pathological Mechanisms and a New Proposal for a Preventive Therapeutic Approach

Affuso, F., Micillo, F., & Fazio, S. (2024) · Biomedicines · doi:10.3390/biomedicines12081888 · Cited by 23 · see citing works

Circulating arginine metabolites in Alzheimer’s disease and vascular dementia: A systematic review and meta-analysis

Zinellu, A., Tommasi, S., Sedda, S., & Mangoni, A. A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102139 · Cited by 22 · see citing works

Based on Network Pharmacology and Molecular Dynamics Simulations, Baicalein, an Active Ingredient of Yiqi Qingre Ziyin Method, Potentially Protects Patients With Atrophic Rhinitis From Cognitive Impairment

Kang, X., Sun, Y., Yi, B., Jiang, C., Yan, X., Chen, B., Lu, L., Shi, F., Luo, Y., Chen, Y., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.880794 · Cited by 19 · see citing works

Nootropic foods in neurodegenerative diseases: mechanisms, challenges, and future

Nguyen, L. A. M., Simons, C. W., & Thomas, R. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00476-7 · Cited by 17 · see citing works

Association between Blood Pressure, Blood Pressure Variability, and Post-Stroke Cognitive Impairment

Lee, K., Chang, A. Y., & Sung, P. (2021) · Biomedicines · doi:10.3390/biomedicines9070773 · Cited by 16 · see citing works

Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer’s Disease: A Targeted Transcriptome Analysis

Ma, C., Hunt, J. B., Kovalenko, A., Liang, H., Selenica, M. B., Orr, M. B., Zhang, B., Gensel, J. C., Feola, D. J., Gordon, M. N., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628156 · Cited by 16 · see citing works

Exploring the pharmacological mechanism of Bu-Wang San on Alzheimer's disease through multiple GEO datasets of the human hippocampus, network pharmacology, and metabolomics based on GC-MS and UPLC-Q/TOF-MS

Wang, H., Chao, L., Shen, S., You, P., Li, L., Chen, X., Hong, Z., & Chai, Y. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119994 · Cited by 13 · see citing works

Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects

İş, Ö., Min, Y., Wang, X., Oatman, S. R., Daniel, A. A., & Ertekin‐Taner, N. (2024) · Glia · doi:10.1002/glia.24652 · Cited by 13 · see citing works

Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway

Bednarz-Misa, I. S., Fortuna, P., Fleszar, M. G., Lewandowski, Ł., Diakowska, D., Rosińćzuk, J., & Krzystek‐Korpacka, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176282 · Cited by 13 · see citing works

Construction of an Exudative Age-Related Macular Degeneration Diagnostic and Therapeutic Molecular Network Using Multi-Layer Network Analysis, a Fuzzy Logic Model, and Deep Learning Techniques: Are Retinal and Brain Neurodegenerative Disorders Related?

Latifi‐Navid, H., Behrooz, A. B., Jamehdor, S., Davari, M., Latifinavid, M., Zolfaghari, N., Piroozmand, S., Taghizadeh, S., Bourbour, M., Shemshaki, G., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16111555 · Cited by 13 · see citing works

Impact of Alterations in Homocysteine, Asymmetric Dimethylarginine and Vitamins-Related Pathways in Some Neurodegenerative Diseases: A Narrative Review

Saija, C., Currò, M., Ientile, R., Caccamo, D., & Bertuccio, M. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083672 · Cited by 11 · see citing works

Changes in arginine metabolism in advanced Alzheimer's patients: Experimental and theoretical analyses

Sarı, İ., Erşan, S., Özmen, E., Ayan, D., Erşan, E. E., Бериша, А., & Kaya, S. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.135254 · Cited by 11 · see citing works

SDMA as a marker and mediator in cerebrovascular disease

Riddell, A., Flynn, A., Bergugnat, H., Dowsett, L., & Miller, A. A. (2024) · Clinical Science · doi:10.1042/cs20241021 · Cited by 10 · see citing works

Neurobiochemical characteristics of arginine-rich peptides explain their potential therapeutic efficacy in neurodegenerative diseases

Eskandari, S., Rezayof, A., Asghari, S. M., & Hashemizadeh, S. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102356 · Cited by 10 · see citing works

Levels of Biological Markers of Nitric Oxide in Serum of Patients with Mandible Fractures

Woźniak, Ł., Ratajczak–Wrona, W., Borys, J., Antonowicz, B., Nowak, K., Bortnik, P., & Jabłońska, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132832 · Cited by 9 · see citing works

Arginine and citrulline as nutraceuticals: efficacy and safety in diseases

Kaore, S. N., & Kaore, N. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00055-0 · Cited by 9 · see citing works

Urine metabolic phenotyping in children with nocturnal enuresis and comorbid neurobehavioral disorders

Yu, M., Wang, T.-M., Chiou, Y., Yu, M.-K., Lin, C.-F., & Chiu, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-96104-1 · Cited by 9 · see citing works

Extensive multiregional urea elevations in a case-control study of vascular dementia point toward a novel shared mechanism of disease amongst the age-related dementias

Philbert, S. A., Xu, J., Scholefield, M., Patassini, S., Church, S. J., Unwin, R. D., Roncaroli, F., & Cooper, G. J. S. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1215637 · Cited by 8 · see citing works

Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment

Russin, K. J., Nair, K. S., Montine, T. J., Baker, L. D., & Craft, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210471 · Cited by 8 · see citing works

Gadd45A-mediated autophagy regulation and its impact on Alzheimer's disease pathogenesis: Deciphering the molecular Nexus

Althobaiti, N. A., Al-Abbas, N. S., Alsharif, I., Albalawi, A. E., Almars, ‏. I., Basabrain, A. A., Jafer, A., Ellatif, S. A. A., Bauthman, N. M., Almohaimeed, H. M., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167353 · Cited by 7 · see citing works

Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis

Phua, T. J. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1196648 · Cited by 7 · see citing works

Impact of supplementation with L-citrulline/arginine after liver transplantation in individuals with Urea Cycle Disorders

Posset, R., Garbade, S. F., Gleich, F., Nagamani, S. C. S., Gropman, A. L., Epp, F., Ramdhouni, N., Druck, A., Hoffmann, G. F., Kölker, S., et al. (2023) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2023.108112 · Cited by 7 · see citing works

Nutrition and Brain Functions in Health and Disease

Mansour, H. M. (2022) · Nutritional neurosciences · doi:10.1007/978-981-19-5021-6_1 · Cited by 7 · see citing works

Unraveling the potential of gasotransmitters as neurogenic and neuroprotective molecules: focus on Alzheimer’s and Parkinson’s diseases

Simão, S., Santos, D. F., Teixeira, M., Agostinho, R., Rodrigues, J., Vitorino, M., & Araújo, I. (2025) · Redox Report · doi:10.1080/13510002.2025.2592413 · Cited by 8 · see citing works

Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b

Hosseini-Gerami, L., Ficulle, E., Humphryes-Kirilov, N., Airey, D. C., Scherschel, J., Kananathan, S., Eastwood, B. J., Bose, S., Collier, D. A., Laing, E., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01182-0 · Cited by 6 · see citing works

Chronometabolism: The Timing of the Consumption of Meals Has a Greater Influence Than Glycemic Index (GI) on the Postprandial Metabolome

Yong, Y. N., Dong, J., Pakkiri, L. S., Henry, C. J., Haldar, S., & Drum, C. L. (2023) · Metabolites · doi:10.3390/metabo13040490 · Cited by 7 · see citing works

Metabolomics – an overview. From basic principles to potential biomarkers (part 2)

Dufour-Rainfray, D., Lambérioux, M., Boulard, P., Guidotti, M., Delaye, J.-B., Ribeiro, M.-J., Gauchez, A., Balageas, A.-C., Emond, P., & Agin, A. (2020) · Médecine Nucléaire · doi:10.1016/j.mednuc.2020.02.004 · Cited by 6 · see citing works

The impact of mGlu2 or mGlu5 receptor activators on the production of l-arginine derivatives and the expression of PRMT5 or DDAH1 enzymes in animal models of cognitive decline

Płoska, A., Radulska, A., Siekierzycka, A., Cieślik, P., Santocki, M., Dobrucki, I. T., Kalinowski, L., & Wierońska, J. M. (2024) · Nitric Oxide · doi:10.1016/j.niox.2024.11.010 · Cited by 5 · see citing works

Measurement of Serum Levels of 5 Amino Acids and Dimethylamine Using Liquid Chromatography-Tandem Mass Spectrometry in Patients without Septic Associated Acute Kidney Injury and with Septic Associated Acute Kidney Injury Requiring Continuous Renal Replacement Therapy

Leśnik, P., Łysenko, L., Fleszar, M. G., Fortuna, P., Woźnica-Niesobska, E., Mierzchała-Pasierb, M., & Janc, J. (2022) · Medical Science Monitor · doi:10.12659/msm.937784 · Cited by 5 · see citing works

WIF-1 contributes to lupus-induced neuropsychological deficits via the CRYAB/STAT4-SHH axis

Tan, L., Fan, Y., Xu, X., Zhang, T., Cao, X., Zhang, C., Liang, J., Hou, Y., & Dou, H. (2024) · Arthritis Research & Therapy · doi:10.1186/s13075-024-03420-8 · Cited by 5 · see citing works

Altered metabolic function induced by Aβ‐oligomers and PSEN1 mutations in iPSC ‐derived astrocytes

Elsworthy, R. J., Finelli, M. J., Aqattan, S., Dunleavy, C., King, M. C., Ludlam, A., Tarczyluk, M. A., Allen, S., Prosser, S., Chen, R., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16267 · Cited by 4 · see citing works

Neuroprotective effect of Hypericum perforatum extract against Aluminum-maltolate induced toxicity in SH-SY5Y cells

AKKUŞ, R. Y., BİTMEZ, B., GÜLTEKİN, S. K., ALBAYRAK, İ. G., Özen, F., DEVECİ, Y., Sıcak, Y., Akalın, E., Pırhan, A. F., & Arslan, B. A. (2022) · International Journal of Science Letters · doi:10.38058/ijsl.1121636 · Cited by 4 · see citing works

Emerging role of metabolomics in protein conformational disorders

Gupta, N., Ramakrishnan, S., & Wajid, S. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1948330 · Cited by 3 · see citing works

Alteration of Metabolic Profile in Patients with Narcolepsy Type 1

Hakim, M. A., Purba, W. T., Sanni, A., Bhuiyan, M. M. A. A., Talih, F. R., Lanza, G., Kobeissy, F. H., Plazzi, G., Pizza, F., Ferri, R., et al. (2025) · Metabolites · doi:10.3390/metabo15060382 · Cited by 3 · see citing works

The Characteristics of the Metabolomic Profile in Patients with Parkinson’s Disease and Vascular Parkinsonism

Predtechenskaya, E. V., Rogachev, A. D., & Melnikova, P. M. (2024) · Acta Naturae · doi:10.32607/actanaturae.27511 · Cited by 2 · see citing works

Metabolites of L-ARG in Exhaled Breath Condensate and Serum Are Not Biomarkers of Bronchial Asthma in Children

Połomska, J., & Sozańska, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11010252 · Cited by 2 · see citing works

Altered metabolic function induced by amyloid-beta oligomers and PSEN1-mutations in iPSC-derived astrocytesPreprint

Elsworthy, R. J., Finelli, M. J., Aqattan, S., Dunleavy, C., King, M. C., Ludlam, A., Allen, S. L., Prosser, S., Chen, R. E., Martínez‐Jarquín, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.23.554346 · Cited by 2 · see citing works

Increased level of serum asymmetric dimethylarginine in individuals with more severe cognitive impairment, as evaluated using Montreal Cognitive Assessment instead of Mini-Mental State Examination

Liu, L., Guan, J., Song, Z., Gao, Q., Cheng, S.-J., Yan, Z., & Fan, Y. (2025) · BMC Psychology · doi:10.1186/s40359-025-02715-y · Cited by 1 · see citing works

Neuroprotective effects of dietary inclusions of alligator pepper ( Aframomum melegueta ) and bastard melegueta ( Aframomum danielli ) seeds on scopolamine-induced amnesia in rats

Agunloye, O. M., Olawuyi, E. A., & Oboh, G. (2025) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2024-0450 · Cited by 1 · see citing works

Mapping cerebrospinal fluid biomarkers to dementia risk through Mendelian randomization

Zhu, X., Chen, W., Zhuo, G., Yang, C., Fu, Y., Huang, Y., Zhang, Y., Liao, H., & Wu, L. (2025) · Medicine · doi:10.1097/md.0000000000044658 · Cited by 1 · see citing works

Unraveling the role of polyamine metabolism in postoperative delirium: insights into biochemical mechanisms and biomarker potential

Saiyed, N., Pandya, V. K., Pan, X., Čuperlović‐Culf, M., Ashrafi, N., Kant, S., Migaud, M. E., Dhuguru, J., Zetterberg, H., McGuinness, B., et al. (2026) · npj Aging · doi:10.1038/s41514-025-00324-y · Cited by 1 · see citing works

Dysregulation of arginase and arginine pathways in neurodegenerative diseases: Metabolic and cellular dysfunction and therapeutic implications

Nalepa, M., Skweres, A., & Węgrzynowicz, M. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.285 · Cited by 1 · see citing works

The Janus face of L-arginine supplementation in cardiovascular health and aging exploration of underlying mechanisms

Yang, Z., Ming, X., & Potenza, D. M. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1880662 · Cited by 1 · see citing works

Comparing Symmetric Dimethylarginine and Amyloid-β42 as Predictors of Alzheimer’s Disease Development

Goodman, M., Li, X. R., Livschitz, J., Huang, C., Bendlin, B. B., Granadillo, E. D., & Initiative, A. D. N. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230054 · Cited by 1 · see citing works

A systematic review and meta-analysis of pteridines in mild cognitive impairment and Alzheimer’s disease

Mangoni, A. A., & Zinellu, A. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-05760-9 · Cited by 1 · see citing works

Levels of Biological Markers of Nitric Oxide in Serum of Patients with Mandible FacturesPreprint

Ratajczak–Wrona, W., Woźniak, Ł., Borys, J., Antonowicz, B., Nowak, K., Bortnik, P., & Jabłońska, E. (2020) · doi:10.21203/rs.2.21730/v1

Extensive multiregional urea elevations in vascular dementia point towards a novel shared mechanism of disease amongst the age-related dementiasPreprint

Philbert, S. A., Xu, J., Scholefield, M., Patassini, S., Church, S. J., Unwin, R. D., Roncaroli, F., & Cooper, G. J. S. (2022) · Research Square · doi:10.21203/rs.3.rs-1670831/v1

Evaluating the Role of Informatics Systems in Early Detection and Monitoring of Dementia Progression

Varma, P., Ratna, S., & Sahoo, S. (2023) · Seminars in Medical Writing and Education · doi:10.56294/mw2023125

Additional file 6 of Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b

Hosseini-Gerami, L., Ficulle, E., Humphryes-Kirilov, N., Airey, D. C., Scherschel, J., Kananathan, S., Eastwood, B. J., Bose, S., Collier, D. A., Laing, E., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22618886

Unraveling the impact of common medications on biomarker patterns in Alzheimer's disease and mild cognitive impairment

Paez, K., Kopachik, C., Yılmaz, A., Vishweswaraiah, S., Ashrafi, N., Saiyed, N., Monacelli, N., Kerševičiūtė, I., Gordevicius, J., Ruff, S., et al. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251387281

Research progress on vascular endothelial growth factor C in meningeal lymphatic vessel-mediated clearance of amyloid β-protein

Zhaoxie, Y. U., Yao, W. A. N. G., Li, Y., Feng, S. H. E. N., & Yanchun, W. A. N. G. (2026) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2025-0549

Salivary metabolomics for early detection of vascular contributions to cognitive impairment and dementia: Exploring microbiome dysbiosis and sex differences

Yilmaz, A., Ashrafi, N., Guerra, Z., Goniwiecha, D., Saiyed, N., Gordevičius, J., Krinickis, K., Gabrielaitė, M., Osentoski, T., Schumacher, N., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261423158

Metabolomic levels mediate the link between socioeconomic factors and changes in declarative memory in women with and without HIV

Tejera, C. H., Dastgheyb, R. M., Shorer, E. F., Lee, S., Gustafson, D., Sharma, A., DʼSouza, G., Weber, K. M., Qi, Q., Rubin, L. H., et al. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101223

Brain neurovascular unit biomarkers: a hypothesis-driven paradigm to advance understanding of post-cardiac arrest cerebral injury

Bellal, M., Goursaud, S., Rubio, M., Martinaud, O., Vivien, D., du Cheyron, D., & Daubin, C. (2026) · Annals of Intensive Care · doi:10.1016/j.aicoj.2026.100064

A review on the therapeutic potential of nitric oxide (NO) in dementia management

Khandker, S. S., Uddin, E., Islam, D. Z., Jahan, R., Farhin, L., Uddin, J., Islam, F., Haque, A., Rahat, S. I., Iffat, N., et al. (2025) · Neurophysiology · doi:10.1007/s11062-026-10000-w

Sex-Specific lipid peroxidation profile and clinical features in a cognitive impairment cohort

Ferré‐González, L., Peña‐Bautista, C., López‐Nogueroles, M., Durand, T., Baquero, M., & Cháfer‐Pericás, C. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.04.143

Low-Intensity Focused Ultrasound Alters Alzheimer’s Disease Pathology, In Vivo, as a Function of Ultrasound Dose and Age

Phutirat, A., Culevski, K., Mach, H., Kwon, J., Tan, H., Koh, G., Marzban, C., & Mourad, P. D. (2026) · Brain Sciences · doi:10.3390/brainsci16070757

Dimethylarginine Dimethylaminohydrolase 1 (DDAH1)-Arginine Metabolic Axis Is Independently Associated With Alzheimer’s Disease Risk in the UK Biobank

Lehrer, S. P., & Rheinstein, P. H. (2026) · Cureus · doi:10.7759/cureus.114415

The beneficial properties of CBDA in diet-induced neuroinflammation

Konstantynowicz-Nowicka, K., Opęchowska, A., Domalewski, M., Zabielska-Kaczorowska, M. A., Bogucka, A. E., Lipiński, M., Harasim‐Symbor, E., & Chabowski, A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02358-4

Mild traumatic brain injury promotes chronic cerebrovascular inflammation and glymphatic suppression

Eisenbaum, M., Pearson, A., Cembran, A., Mufson, E. J., Ortiz, C., Spelman, M., MULLAN, M. J., Crawford, F., Ojo, J. O., & Bachmeier, C. J. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00053-w

Circulating arginine metabolites in Alzheimer’s disease and vascular dementia: A systematic review and meta-analysis

Zinellu, A., Tommasi, S., Sedda, S., & Mangoni, A. A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102139 · Cited by 22 · see citing works

Altered arginine metabolism in Alzheimer's disease brains

Liu, P., Fleete, M. S., Yu, J., Collie, N. D., Curtis, M. A., Waldvogel, H. J., Faull, R. L. M., Abraham, W. C., & Zhang, H. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.013 · Cited by 186 · see citing works

L-Arginine and Its Metabolites in Age-Related Cerebral Small Vessel Disease with Cognitive Impairment

Добрынина, Л. А., Byrochkina, A., Витальевна, Ш. К., Kremneva, E., Zabitova, M. R., & Шабалина, А. А. (2026) · Biomolecules · doi:10.3390/biom16060914

Brain Arginine Metabolism in Early‐onset Alzheimer’s Disease and Frontotemporal Dementia

Mein, H., Yu, J., Lladó, A., Zhang, H., & Liu, P. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.075958 · Cited by 1 · see citing works

Altered Plasma Global Arginine Bioavailability Ratio in Early-stage Alzheimer’s Disease

Martı́nez-Martos, J. M., Pulido-Navas, M. E., & Ramı́rez-Expósito, M. J. (2018) · The Open Biomarkers Journal · doi:10.2174/1875318301808010034 · Cited by 4 · see citing works